EMERGE

Meta-analysis of the latest anti-amyloid immunotherapies: benefit vs risk 5:48
Meta-analysis of the latest anti-amyloid immunotherapies: benefit vs risk
Nicolas Villain • 6 Dec 2022
Impact of Alzheimer’s disease treatments on apathy 3:17
Impact of Alzheimer’s disease treatments on apathy
Krista Lanctôt • 11 Aug 2022
Is amyloid lowering still a valid approach in Alzheimer’s disease? 2:24
Is amyloid lowering still a valid approach in Alzheimer’s disease?
Johannes Streffer • 2 Aug 2022
The future of Alzheimer’s disease: aducanumab 2:38
The future of Alzheimer’s disease: aducanumab
John Hardy • 20 Oct 2020
Hopeful developments for Alzheimer’s Disease 1:21
Hopeful developments for Alzheimer’s Disease
Bart De Strooper
The content of VJDementia is intended for healthcare professionals